• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BCT
Click for more information
0.00% 0.3¢

BLUECHIIP LIMITED - Announcements

Market Cap $4.737M  ! watchlist Created with Sketch. Add to my watchlist

Bluechiip Limited is an Australia-based company, which is engaged in the development of... Bluechiip Limited is an Australia-based company, which is engaged in the development of advanced sample management solutions for harsh environments. The principal activity of the Company is the development and commercialization of a wireless tracking solution for the healthcare and life science, security, defense, and manufacturing industries. Its solutions include Bluechiip Enabled Solutions, Custom Solutions and Partnerships. The Company offers a range of services across product design, engineering and manufacturing. It also offers partners the ability to license its patented technology to differentiate their product and service offerings. The Company's Sample Storage solutions include Bluechiip Enabled CryoVial Range, Bluechiip Enabled CryoBoxes, Bluechiip Enabled CryoTags and a range of accessories for all advanced sample management needs. Its Readers solutions include Bluechiip Enabled Handheld Reader, Bluechiip Enabled Multivial Reader and Bluechiip Enabled CryoBox Tracker.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BCT Broker PresentationPRICE SENSITIVE26/03/19
BCT Open BriefingPRICE SENSITIVE26/02/19
BCT Half Yearly Report and AccountsPRICE SENSITIVE25/02/19
BCT Open Briefing30/01/19
BCT Appendix 4C - quarterlyPRICE SENSITIVE30/01/19
BCT Change of Director's Interest Notice21/12/18
BCT Appendix 3B and 708A(5) Notice13/12/18
BCT Final Director's Interest Notice29/11/18
BCT Results of Meeting26/11/18
BCT Board Change26/11/18
BCT AGM Presentation26/11/18
BCT Notice of Annual General Meeting/Proxy Form24/10/18
BCT Open Briefing interview with MD Andrew McLellan18/10/18
BCT Appendix 4C - quarterlyPRICE SENSITIVE18/10/18
BCT Ceasing to be a substantial holder09/10/18
BCT Appendix 3B - SPP Shares04/10/18
BCT BCT raises $1.95M in Share Purchase PlanPRICE SENSITIVE03/10/18
BCT Change of Registry Address: Automic P/L - Sydney Office28/09/18
BCT Appendix 4G24/09/18
BCT Corporate Governance Statement24/09/18
BCT Annual Report to shareholders24/09/18
BCT Change in substantial holding14/09/18
BCT Share Purchase Plan (SPP) Offer14/09/18
BCT App 3B - Completion of Placement14/09/18
BCT BCT Raises $5.5M and Announces Share Purchase PlanPRICE SENSITIVE10/09/18
BCT Trading HaltPRICE SENSITIVE06/09/18
BCT Open Briefing interview with MD Andrew McLellan31/08/18
BCT BCT signs three-year A$15.9M supply deal with LabconPRICE SENSITIVE29/08/18
BCT Bluechiip FY18 Highlights28/08/18
BCT Preliminary Final ReportPRICE SENSITIVE28/08/18
BCT Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
BCT Open Briefing interview with MD Andrew McLellanPRICE SENSITIVE25/06/18 download Created with Sketch. 265.98KB
BCT Change of Director's Interest Notice18/06/18 download Created with Sketch. 189.01KB
BCT CommSec Executive Series Interview With Andrew McLellan24/04/18
BCT Appendix 4C - quarterlyPRICE SENSITIVE23/04/18
BCT Presentation to Goldman Sachs Small & Midcap Conference17/04/18
BCT Corporate Overview and March 2018 UpdatePRICE SENSITIVE14/03/18
BCT Open Briefing - 1H FY18 results and outlookPRICE SENSITIVE27/02/18
BCT Half Yearly Report and AccountsPRICE SENSITIVE26/02/18
BCT Labcon begins production of Bluechiip-enabled consumablesPRICE SENSITIVE19/02/18
BCT Appendix 4C - quarterlyPRICE SENSITIVE22/01/18
BCT Update on A$1 million initial order15/12/17
BCT Change of Director's Interest Notice08/12/17
BCT Open Briefing interview with MD/CEO Andrew McLellan07/12/17
BCT Appendix 3Y07/12/17
BCT Appendix 3Y07/12/17
BCT Appendix 3B and 708A Notice07/12/17
BCT Bluechiip receives A$1M order from US PartnerPRICE SENSITIVE05/12/17
BCT Results of Meeting13/11/17
BCT AGM Presentation13/11/17
BCT Appendix 3Y25/10/17
BCT Bluechiip Limited Corporate Video. 'Preparing for Growth'23/10/17
BCT Appendix 3B - Issue of Securities20/10/17
BCT Company update - scaling productionPRICE SENSITIVE19/10/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE17/10/17
BCT Notice of Annual General Meeting/Proxy Form12/10/17
BCT Annual Report (re-lodged)30/08/17
BCT Appendix 4G30/08/17
BCT Corporate Governance Statement30/08/17
BCT Annual Report30/08/17
BCT Preliminary Final ReportPRICE SENSITIVE30/08/17
BCT Initial Director's Interest Notice24/08/17
BCT Bluechiip Appoints Blair Healy as Non-Executive Director23/08/17
BCT Initial Director's Interest Notice28/07/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE27/07/17
BCT Andrew Cox appointed as non-executive director26/07/17
BCT Becoming a substantial holder19/07/17
BCT Becoming a substantial holder18/07/17
BCT Issue of Rights Issue Shortfall Shares / Appendix 3B17/07/17
BCT Change of Share Registry17/07/17
BCT Change of Director's Interest Notice (x3)14/07/17
BCT Rights issue allotment completed07/07/17
BCT Bluechiip raises $3.425M from rights issue and placementPRICE SENSITIVE05/07/17
BCT Company UpdatePRICE SENSITIVE21/06/17
BCT Rights Issue - Dispatch of Offer Document13/06/17
BCT Rights Issue - Letters to Shareholders06/06/17
BCT Cleansing Notice under s 708AA(2)(f)05/06/17
BCT Rights Issue Offer DocumentPRICE SENSITIVE05/06/17
BCT Cleansing Notice and Appendix 3B05/06/17
BCT Rights IssuePRICE SENSITIVE01/06/17
BCT Investor Presentation27/04/17
BCT Open Briefing with MD/CEO Andrew McLellanPRICE SENSITIVE27/04/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE21/04/17
BCT Major Agreement Signed With Labcon North AmericaPRICE SENSITIVE10/04/17
BCT Half Yearly Report and AccountsPRICE SENSITIVE22/02/17
BCT Appendix 3B25/01/17
BCT Appendix 4C - quarterlyPRICE SENSITIVE25/01/17
BCT Appendix 3Y - Kirkwood, McLellan and Ohanessian16/12/16
BCT Appendix 3B16/12/16
BCT CEO Interview / Open BriefingPRICE SENSITIVE08/12/16
BCT Results of Meeting25/11/16
BCT AGM Presentation25/11/16
BCT BCT receives funding for over-temperature R&DPRICE SENSITIVE17/11/16
BCT Sales of Starter Kits to two key institutionsPRICE SENSITIVE09/11/16
BCT Notice of Annual General Meeting/Proxy Form-BCT.AX 25/10/16
BCT Appendix 4G-BCT.AX 25/10/16
BCT Corporate Governance Statement-BCT.AX 25/10/16
BCT Annual Report to shareholders-BCT.AX 25/10/16
BCT Appendix 4C - quarterly-BCT.AX PRICE SENSITIVE25/10/16
BCT Appendix 3B (revised)-BCT.AX 14/10/16
BCT Broker Presentation
26/03/19PRICE SENSITIVE
BCT Open Briefing
26/02/19PRICE SENSITIVE
BCT Half Yearly Report and Accounts
25/02/19PRICE SENSITIVE
BCT Open Briefing
30/01/19
BCT Appendix 4C - quarterly
30/01/19PRICE SENSITIVE
BCT Change of Director's Interest Notice
21/12/18
BCT Appendix 3B and 708A(5) Notice
13/12/18
BCT Final Director's Interest Notice
29/11/18
BCT Results of Meeting
26/11/18
BCT Board Change
26/11/18
BCT AGM Presentation
26/11/18
BCT Notice of Annual General Meeting/Proxy Form
24/10/18
BCT Open Briefing interview with MD Andrew McLellan
18/10/18
BCT Appendix 4C - quarterly
18/10/18PRICE SENSITIVE
BCT Ceasing to be a substantial holder
09/10/18
BCT Appendix 3B - SPP Shares
04/10/18
BCT BCT raises $1.95M in Share Purchase Plan
03/10/18PRICE SENSITIVE
BCT Change of Registry Address: Automic P/L - Sydney Office
28/09/18
BCT Appendix 4G
24/09/18
BCT Corporate Governance Statement
24/09/18
BCT Annual Report to shareholders
24/09/18
BCT Change in substantial holding
14/09/18
BCT Share Purchase Plan (SPP) Offer
14/09/18
BCT App 3B - Completion of Placement
14/09/18
BCT BCT Raises $5.5M and Announces Share Purchase Plan
10/09/18PRICE SENSITIVE
BCT Trading Halt
06/09/18PRICE SENSITIVE
BCT Open Briefing interview with MD Andrew McLellan
31/08/18
BCT BCT signs three-year A$15.9M supply deal with Labcon
29/08/18PRICE SENSITIVE
BCT Bluechiip FY18 Highlights
28/08/18
BCT Preliminary Final Report
28/08/18PRICE SENSITIVE
BCT Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
BCT Open Briefing interview with MD Andrew McLellan
25/06/18PRICE SENSITIVE download Created with Sketch. 265.98KB
BCT Change of Director's Interest Notice
18/06/18 download Created with Sketch. 189.01KB
BCT CommSec Executive Series Interview With Andrew McLellan
24/04/18
BCT Appendix 4C - quarterly
23/04/18PRICE SENSITIVE
BCT Presentation to Goldman Sachs Small & Midcap Conference
17/04/18
BCT Corporate Overview and March 2018 Update
14/03/18PRICE SENSITIVE
BCT Open Briefing - 1H FY18 results and outlook
27/02/18PRICE SENSITIVE
BCT Half Yearly Report and Accounts
26/02/18PRICE SENSITIVE
BCT Labcon begins production of Bluechiip-enabled consumables
19/02/18PRICE SENSITIVE
BCT Appendix 4C - quarterly
22/01/18PRICE SENSITIVE
BCT Update on A$1 million initial order
15/12/17
BCT Change of Director's Interest Notice
08/12/17
BCT Open Briefing interview with MD/CEO Andrew McLellan
07/12/17
BCT Appendix 3Y
07/12/17
BCT Appendix 3Y
07/12/17
BCT Appendix 3B and 708A Notice
07/12/17
BCT Bluechiip receives A$1M order from US Partner
05/12/17PRICE SENSITIVE
BCT Results of Meeting
13/11/17
BCT AGM Presentation
13/11/17
BCT Appendix 3Y
25/10/17
BCT Bluechiip Limited Corporate Video. 'Preparing for Growth'
23/10/17
BCT Appendix 3B - Issue of Securities
20/10/17
BCT Company update - scaling production
19/10/17PRICE SENSITIVE
BCT Appendix 4C - quarterly
17/10/17PRICE SENSITIVE
BCT Notice of Annual General Meeting/Proxy Form
12/10/17
BCT Annual Report (re-lodged)
30/08/17
BCT Appendix 4G
30/08/17
BCT Corporate Governance Statement
30/08/17
BCT Annual Report
30/08/17
BCT Preliminary Final Report
30/08/17PRICE SENSITIVE
BCT Initial Director's Interest Notice
24/08/17
BCT Bluechiip Appoints Blair Healy as Non-Executive Director
23/08/17
BCT Initial Director's Interest Notice
28/07/17
BCT Appendix 4C - quarterly
27/07/17PRICE SENSITIVE
BCT Andrew Cox appointed as non-executive director
26/07/17
BCT Becoming a substantial holder
19/07/17
BCT Becoming a substantial holder
18/07/17
BCT Issue of Rights Issue Shortfall Shares / Appendix 3B
17/07/17
BCT Change of Share Registry
17/07/17
BCT Change of Director's Interest Notice (x3)
14/07/17
BCT Rights issue allotment completed
07/07/17
BCT Bluechiip raises $3.425M from rights issue and placement
05/07/17PRICE SENSITIVE
BCT Company Update
21/06/17PRICE SENSITIVE
BCT Rights Issue - Dispatch of Offer Document
13/06/17
BCT Rights Issue - Letters to Shareholders
06/06/17
BCT Cleansing Notice under s 708AA(2)(f)
05/06/17
BCT Rights Issue Offer Document
05/06/17PRICE SENSITIVE
BCT Cleansing Notice and Appendix 3B
05/06/17
BCT Rights Issue
01/06/17PRICE SENSITIVE
BCT Investor Presentation
27/04/17
BCT Open Briefing with MD/CEO Andrew McLellan
27/04/17PRICE SENSITIVE
BCT Appendix 4C - quarterly
21/04/17PRICE SENSITIVE
BCT Major Agreement Signed With Labcon North America
10/04/17PRICE SENSITIVE
BCT Half Yearly Report and Accounts
22/02/17PRICE SENSITIVE
BCT Appendix 3B
25/01/17
BCT Appendix 4C - quarterly
25/01/17PRICE SENSITIVE
BCT Appendix 3Y - Kirkwood, McLellan and Ohanessian
16/12/16
BCT Appendix 3B
16/12/16
BCT CEO Interview / Open Briefing
08/12/16PRICE SENSITIVE
BCT Results of Meeting
25/11/16
BCT AGM Presentation
25/11/16
BCT BCT receives funding for over-temperature R&D
17/11/16PRICE SENSITIVE
BCT Sales of Starter Kits to two key institutions
09/11/16PRICE SENSITIVE
BCT Notice of Annual General Meeting/Proxy Form-BCT.AX
25/10/16
BCT Appendix 4G-BCT.AX
25/10/16
BCT Corporate Governance Statement-BCT.AX
25/10/16
BCT Annual Report to shareholders-BCT.AX
25/10/16
BCT Appendix 4C - quarterly-BCT.AX
25/10/16PRICE SENSITIVE
BCT Appendix 3B (revised)-BCT.AX
14/10/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.737M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
BCT (ASX) Chart

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.